The Role of Urine Drug Testing for Patients on Opioid Therapy

Joseph Pergolizzi, Macro Pappagallo, Joseph Stauffer, Christopher Gharibo, Neil Fortner, Mathew N. De Jesus, Michael J. Brennan, Charlotte Richmond, Desmond Hussey

Research output: Contribution to journalArticle

Abstract

Opioid analgesics must be prescribed with discernment and their appropriate use should be periodically assessed. Urine drug testing, although not designed specifically for this role, is a widely available and familiar method for monitoring opioid use in chronic pain patients. Urine drug testing can help track patient compliance and expose possible drug misuse and abuse. We sought to evaluate current attitudes and practices regarding the use of urine drug testing among chronic pain patients taking opioids. To the best of our knowledge, this is one of the first such attempts in the literature to examine and document the practice patterns of urine drug testing in this context. A total of 99 attendees at the American Congress of Pain Medicine were surveyed in 2008 about their urine testing practices for patients on opioid therapy. Surprisingly, more urine testing was motivated by a desire to detect undisclosed substances than to evaluate appropriate opioid use. Some respondents never urine-tested their opioid patients, and about two-thirds of respondents had no formal training in urine testing of patients on opioid therapy. The literature does not thoroughly address the role of urine drug testing in this patient population. Most respondents did random rather than scheduled testing; few had any urine testing protocol. The study found motivations for urine testing and testing practices varied widely, and urine testing, despite its clinical utility, is not used consistently.

Original languageEnglish (US)
Pages (from-to)497-507
Number of pages11
JournalPain Practice
Volume10
Issue number6
DOIs
StatePublished - Nov 2010

Fingerprint

Opioid Analgesics
Urine
Pharmaceutical Preparations
Therapeutics
Chronic Pain
Patient Compliance
Substance-Related Disorders
Motivation
Medicine
Pain

Keywords

  • Analgesics
  • Narcotics
  • Opioid
  • Opioid analgesics
  • Opioid misuse
  • Opioid therapy
  • Opioids
  • Pain
  • Pain clinics
  • Urine drug testing

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Pergolizzi, J., Pappagallo, M., Stauffer, J., Gharibo, C., Fortner, N., De Jesus, M. N., ... Hussey, D. (2010). The Role of Urine Drug Testing for Patients on Opioid Therapy. Pain Practice, 10(6), 497-507. https://doi.org/10.1111/j.1533-2500.2010.00375.x

The Role of Urine Drug Testing for Patients on Opioid Therapy. / Pergolizzi, Joseph; Pappagallo, Macro; Stauffer, Joseph; Gharibo, Christopher; Fortner, Neil; De Jesus, Mathew N.; Brennan, Michael J.; Richmond, Charlotte; Hussey, Desmond.

In: Pain Practice, Vol. 10, No. 6, 11.2010, p. 497-507.

Research output: Contribution to journalArticle

Pergolizzi, J, Pappagallo, M, Stauffer, J, Gharibo, C, Fortner, N, De Jesus, MN, Brennan, MJ, Richmond, C & Hussey, D 2010, 'The Role of Urine Drug Testing for Patients on Opioid Therapy', Pain Practice, vol. 10, no. 6, pp. 497-507. https://doi.org/10.1111/j.1533-2500.2010.00375.x
Pergolizzi J, Pappagallo M, Stauffer J, Gharibo C, Fortner N, De Jesus MN et al. The Role of Urine Drug Testing for Patients on Opioid Therapy. Pain Practice. 2010 Nov;10(6):497-507. https://doi.org/10.1111/j.1533-2500.2010.00375.x
Pergolizzi, Joseph ; Pappagallo, Macro ; Stauffer, Joseph ; Gharibo, Christopher ; Fortner, Neil ; De Jesus, Mathew N. ; Brennan, Michael J. ; Richmond, Charlotte ; Hussey, Desmond. / The Role of Urine Drug Testing for Patients on Opioid Therapy. In: Pain Practice. 2010 ; Vol. 10, No. 6. pp. 497-507.
@article{0fbd82e2d0c04e5c8b694f06a914fb3f,
title = "The Role of Urine Drug Testing for Patients on Opioid Therapy",
abstract = "Opioid analgesics must be prescribed with discernment and their appropriate use should be periodically assessed. Urine drug testing, although not designed specifically for this role, is a widely available and familiar method for monitoring opioid use in chronic pain patients. Urine drug testing can help track patient compliance and expose possible drug misuse and abuse. We sought to evaluate current attitudes and practices regarding the use of urine drug testing among chronic pain patients taking opioids. To the best of our knowledge, this is one of the first such attempts in the literature to examine and document the practice patterns of urine drug testing in this context. A total of 99 attendees at the American Congress of Pain Medicine were surveyed in 2008 about their urine testing practices for patients on opioid therapy. Surprisingly, more urine testing was motivated by a desire to detect undisclosed substances than to evaluate appropriate opioid use. Some respondents never urine-tested their opioid patients, and about two-thirds of respondents had no formal training in urine testing of patients on opioid therapy. The literature does not thoroughly address the role of urine drug testing in this patient population. Most respondents did random rather than scheduled testing; few had any urine testing protocol. The study found motivations for urine testing and testing practices varied widely, and urine testing, despite its clinical utility, is not used consistently.",
keywords = "Analgesics, Narcotics, Opioid, Opioid analgesics, Opioid misuse, Opioid therapy, Opioids, Pain, Pain clinics, Urine drug testing",
author = "Joseph Pergolizzi and Macro Pappagallo and Joseph Stauffer and Christopher Gharibo and Neil Fortner and {De Jesus}, {Mathew N.} and Brennan, {Michael J.} and Charlotte Richmond and Desmond Hussey",
year = "2010",
month = "11",
doi = "10.1111/j.1533-2500.2010.00375.x",
language = "English (US)",
volume = "10",
pages = "497--507",
journal = "Pain Practice",
issn = "1530-7085",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The Role of Urine Drug Testing for Patients on Opioid Therapy

AU - Pergolizzi, Joseph

AU - Pappagallo, Macro

AU - Stauffer, Joseph

AU - Gharibo, Christopher

AU - Fortner, Neil

AU - De Jesus, Mathew N.

AU - Brennan, Michael J.

AU - Richmond, Charlotte

AU - Hussey, Desmond

PY - 2010/11

Y1 - 2010/11

N2 - Opioid analgesics must be prescribed with discernment and their appropriate use should be periodically assessed. Urine drug testing, although not designed specifically for this role, is a widely available and familiar method for monitoring opioid use in chronic pain patients. Urine drug testing can help track patient compliance and expose possible drug misuse and abuse. We sought to evaluate current attitudes and practices regarding the use of urine drug testing among chronic pain patients taking opioids. To the best of our knowledge, this is one of the first such attempts in the literature to examine and document the practice patterns of urine drug testing in this context. A total of 99 attendees at the American Congress of Pain Medicine were surveyed in 2008 about their urine testing practices for patients on opioid therapy. Surprisingly, more urine testing was motivated by a desire to detect undisclosed substances than to evaluate appropriate opioid use. Some respondents never urine-tested their opioid patients, and about two-thirds of respondents had no formal training in urine testing of patients on opioid therapy. The literature does not thoroughly address the role of urine drug testing in this patient population. Most respondents did random rather than scheduled testing; few had any urine testing protocol. The study found motivations for urine testing and testing practices varied widely, and urine testing, despite its clinical utility, is not used consistently.

AB - Opioid analgesics must be prescribed with discernment and their appropriate use should be periodically assessed. Urine drug testing, although not designed specifically for this role, is a widely available and familiar method for monitoring opioid use in chronic pain patients. Urine drug testing can help track patient compliance and expose possible drug misuse and abuse. We sought to evaluate current attitudes and practices regarding the use of urine drug testing among chronic pain patients taking opioids. To the best of our knowledge, this is one of the first such attempts in the literature to examine and document the practice patterns of urine drug testing in this context. A total of 99 attendees at the American Congress of Pain Medicine were surveyed in 2008 about their urine testing practices for patients on opioid therapy. Surprisingly, more urine testing was motivated by a desire to detect undisclosed substances than to evaluate appropriate opioid use. Some respondents never urine-tested their opioid patients, and about two-thirds of respondents had no formal training in urine testing of patients on opioid therapy. The literature does not thoroughly address the role of urine drug testing in this patient population. Most respondents did random rather than scheduled testing; few had any urine testing protocol. The study found motivations for urine testing and testing practices varied widely, and urine testing, despite its clinical utility, is not used consistently.

KW - Analgesics

KW - Narcotics

KW - Opioid

KW - Opioid analgesics

KW - Opioid misuse

KW - Opioid therapy

KW - Opioids

KW - Pain

KW - Pain clinics

KW - Urine drug testing

UR - http://www.scopus.com/inward/record.url?scp=78049480350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049480350&partnerID=8YFLogxK

U2 - 10.1111/j.1533-2500.2010.00375.x

DO - 10.1111/j.1533-2500.2010.00375.x

M3 - Article

VL - 10

SP - 497

EP - 507

JO - Pain Practice

JF - Pain Practice

SN - 1530-7085

IS - 6

ER -